Sign in

You're signed outSign in or to get full access.

Terrence W. Cavanaugh

Director at SELECTIVE INSURANCE GROUPSELECTIVE INSURANCE GROUP
Board

About Terrence W. Cavanaugh

Independent director of Selective Insurance Group since 2018; age 71. Founding partner at Accretive Consulting (since 2017), former President & CEO of Erie Indemnity (2008–2016), and long-tenured Chubb executive (1975–2007). Education: B.B.A., University of Notre Dame; Program for Management Development, Harvard Business School. Core credentials include >40 years of P&C insurance leadership, distribution, underwriting/operations, risk management, and talent development .

Past Roles

OrganizationRoleTenureCommittees/Impact
Accretive Consulting LLCFounding Partner2017–presentAdvisory work leveraging insurance growth and distribution expertise
Erie Indemnity CompanyPresident & CEO2008–2016Led Fortune 500 insurer; growth in DPW and surplus, profitability, agent relationships
Chubb GroupCOO, Surety & Trade Credit; CMO; underwriting/field roles1975–2007Operations, marketing, underwriting leadership across segments
Insurance Information InstituteChair; Director2011–2016 (Chair 2015–2016)Industry thought leadership and public disclosure expertise
Property Casualty Insurance AssociationChair; Director2008–2017 (Chair 2014–2015)Industry advocacy, risk and regulatory engagement

External Roles

OrganizationRoleTenureNotes
Highmark HealthDirector2013–presentHealth sector board service (not a public P&C competitor)
Naples Airport AuthorityBoard of Commissioners2022–presentLocal government oversight of airport operations
The InstitutesTrustee2010–2016Insurance credentialing and education influence

Board Governance

  • Committee memberships: Audit Committee member; Risk Committee member. Not a chair; Audit Chair is H. Elizabeth Mitchell, Risk Chair is John S. Scheid .
  • Independence: Board determined he is independent under Nasdaq/SEC rules; all members of Audit and Risk Committees are independent .
  • Attendance: Board held 7 meetings in 2024; independent directors met 4 times without management. All directors attended at least 75% of aggregate Board/committee meetings; average attendance >98%; all then-serving directors attended the 2024 annual meeting .
  • Lead independent director: Robert Kelly Doherty (since 2022) .
  • Board refreshment/retirement: Mandatory director retirement age is 72; Cavanaugh is 71, indicating approaching age-based turnover consideration .

Fixed Compensation

Component2024 AmountDetails
Annual Retainer$100,074Directors can elect stock; Cavanaugh elected to take 1,038 shares valued at $100,074
Annual Equity Grant (RSUs)$110,004Unvested RSUs at year-end: 1,141 units; grant under 2024 Omnibus Stock Plan
Committee Chair Fees$0Not a chair; Audit Chair $35k, Risk Chair $25k (program terms)
Committee Member Fees$0SIGI pays member fees only for a third committee ($8k); Cavanaugh serves on two
Total 2024 Director Pay$210,078Fees + stock awards

Performance Compensation

  • Directors do not receive performance-based awards; annual equity is RSUs with service-based vesting. No options or performance metrics disclosed for director equity .

Other Directorships & Interlocks

Company/EntityPublic Company?Potential Interlock/ConflictNotes
Highmark HealthNo (non-profit health)LowNot overlapping with SIGI’s P&C footprint
Naples Airport AuthorityNoLowGovernment board role
Industry associations (III, PCI)NoLowPrior industry associations, no current related-party exposure disclosed

No specific related-party transactions or independence exceptions disclosed for Cavanaugh; Board independence review flagged other directors (Doherty, Mitchell, Sampson), not Cavanaugh .

Expertise & Qualifications

  • Insurance industry, risk management, financial statement/audit/public disclosure, finance/capital management/M&A, investment, agency distribution, technology/cybersecurity, legal/regulatory, marketing/branding, human capital management .

Equity Ownership

MetricValueNotes
Beneficial ownership (2/20/2025)20,659 sharesLess than 1% of class; no margin pledging or pledged shares
Director RSUs unvested (12/31/2024)1,141 unitsProgram RSUs for directors
Insider trades (Form 4)1,000 shares bought @ $98.47 (2/2/2024) ; 2,000 shares bought @ $85.85 (7/23/2024) ; 2,000 shares bought @ $75.72 (7/25/2025)
Ownership guidelines5x annual retainer; all directors met or are on trackCompany-wide disclosure; no individual shortfall noted
Hedging/pledging policyHedging prohibited; pledging oversight by CHCCCompany policy prohibits hedging; CHCC oversees pledging policy

Governance Assessment

  • Committee effectiveness: Placement on Audit and Risk signals Board reliance on his financial reporting, disclosure, and enterprise risk oversight experience; not over-concentrated (no chair role), which mitigates key-person risk .
  • Independence & conflicts: Confirmed independent; no Cavanaugh-specific related-party exposures disclosed; company’s Related Person Policy routes approvals through the Audit Committee and prohibits conflicted members from participating .
  • Engagement: Strong Board-wide attendance (>98% average); all directors ≥75% threshold; Cavanaugh’s insider purchases in 2024–2025 are a positive alignment signal (skin-in-the-game) .
  • Compensation alignment: Director pay mix of retainer and RSUs, with option to take retainer in stock (which Cavanaugh did), supports ownership and alignment; absence of option grants or performance pay reduces pay-for-performance leverage but is consistent with director governance norms .
  • RED FLAGS: None disclosed (no pledging, no related-party transactions tied to Cavanaugh, no attendance issues). Watchlist item: mandatory retirement age 72 suggests potential near-term Board turnover and succession planning need for Audit/Risk bench strength .

Board Governance (Program Overview)

ItemPractice
Majority voting for directorsResignation required if not receiving majority in uncontested elections; CG&N Committee reviews; Board acts within 90 days
Executive sessionsIndependents met 4 times in 2024
Overboarding limitsMax 4 public boards (2 if CEO) with pre-clearance for conflicts/time demands
Clawback policyDodd-Frank compliant, mandatory recoupment on restatements; effective Dec 1, 2023
Say-on-pay support2024 approval >99% of votes cast (climate of shareholder support)

Director Compensation (Program)

TypeAmountNotes
Annual Retainer$100,000Cash or stock election
Annual RSU grant$110,000Under 2024 Omnibus Stock Plan
Committee chair fees$25,000–$35,000Audit $35k; Risk $25k; Finance & Investments $35k; CG&N $25k; CHCC $25k
Third committee member fee$8,000No fees for first two committees
Lead Independent Director$40,000Separate fee

Related Party Transactions (Policy Context)

Audit Committee pre-approves related-party transactions; conflicted members recuse; reviews benefit to Selective, independence impacts, terms vs third parties. 2024 disclosures focus on large holders (BlackRock, Vanguard, Fidelity) and fund services; none attribute transactions to Cavanaugh .

Equity Ownership (Detail)

HolderShares (2/20/2025)% of ClassNotes
Terrence W. Cavanaugh20,659*Less than 1%; no options exercisable; no RSUs vesting within 60 days; no pledging/margin
Unvested RSUs (12/31/2024)1,141N/ADirector RSUs per program

Insider Trades (Recent)

DateActionSharesPriceSource
2024-02-02Purchase1,000$98.47
2024-07-23Purchase2,000$85.85
2025-07-25Purchase2,000$75.72

Governance Assessment Summary

  • Strengths: Deep insurance expertise deployed on Audit and Risk; independent, engaged, with positive insider buying; compensation and equity design promote alignment; robust corporate governance (majority voting, clawback, hedging ban, overboarding limits) .
  • Watch items: Approaching mandatory retirement age could necessitate succession for risk/audit competencies; continued monitoring of insider ownership growth vs director ownership guidelines (company says all directors met/on-track) .
  • No identified conflicts or red flags tied to Cavanaugh in 2024–2025 disclosures .